BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:London Global Cancer Week
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T133000
DTEND;TZID=Europe/London:20261104T153000
DTSTAMP:20261030T211905Z
CREATED:20260904T201533Z
LAST-MODIFIED:20261030T211905Z
UID:10000335-1793799000-1793806200@www.lgcw.org.uk
SUMMARY:New and Innovative strategies in  global cancer prevention: ultrascreening and risk reduction strategies
DESCRIPTION:Register \nGlobal cancer prevention is shifting toward innovative\, proactive approaches like ultrascreening and advanced risk reduction strategies. Ultrascreening utilizes cutting-edge technologies\, such as liquid biopsies and multi-cancer early detection (MCED) blood tests\, to identify malignancies at microscopic or asymptomatic stages. Combined with personalized risk assessment and targeted lifestyle interventions\, these strategies aim to detect cancer earlier than traditional methods\, ultimately lowering global incidence and improving patient survival rates. Focus in selected populations such as young adults and workers will also be discussed. \nDate: Wednesday\, 4th November 2026\nTime: 1:30 p.m. to 3:30 p.m. GMT\nFormat: Online \nSpeakers\n\n\n\nEduardo Cazap\nSLACOM Founding President; Past-President\, Union for International Cancer Control (UICC). Argentina\nWhy Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nCharles Balch\nPresident\, International Society of Oncology Prevention and Treatments (ISOPT); Professor of Surgery\, UT MD Anderson Cancer Center. USA\nInnovative Cancer Prevention Strategies in Young adults and corporate\nJeffrey N. Weitzel\nFounding Director of the Division of Precision Prevention\, The University of Kansas Cancer Center (KUMC). USA\nPersonalized risk assessment (monogenic and polygenic cancer risk assessment)\n\n\nSuyapa Bejarano\nDirector\, Scientific Research and Innovation\, Universidad Católica de Honduras (UNICAH). Honduras\nCurrent realities and future Horizons: Cancer Screening Capacity Across Latin America\nJulia Ismael\nUICC Board Member\, Scientific & Technical Director\, Latin American Cancer Institute Network (ILACC). Argentina\nWhy Is Cancer Prevention Falling Short? Bridging the Gap Between Innovation and Population Impact\nMaira Caleffi\nUICC Board Member. Chief of the Breast Cancer Center\, Hospital Moinhos de Vento. Brazil\nCan Patient Advocacy Help Identify High Risk Women and Turn Cancer Prevention Innovation into Equitable Access?\n\n\n\nProgramme\n13:30 to 13:50 GMT | Why Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nEduardo Cazap \n13:50 to 14:10 GMT | Innovative Cancer Prevention Strategies in Young adults and corporate\nCharles Balch \n14:10 to 14:30 GMT | Personalized risk assessment (monogenic and polygenic cancer risk assessment)\nJeffrey N. Weitzel \n14:30 to 14:50 GMT | Current realities and future Horizons: Cancer Screening Capacity Across Latin America\nSuyapa Bejarano \n14:50 to 15:10 GMT | Why Is Cancer Prevention Falling Short? Bridging the Gap Between Innovation and Population Impact\nJulia Ismael \n15:10 to 15:30 GMT | Can Patient Advocacy Help Identify High Risk Women and Turn Cancer Prevention Innovation into Equitable Access?\nMaira Caleffi \n\nSESIÓN DE SLACOM · MIÉRCOLES 4 DE NOVIEMBRE DE 2026 \nNuevas e innovadoras estrategias para la prevención global del cáncer: ultrascreening y estrategias de reducción del riesgo\nLa prevención global del cáncer está avanzando hacia enfoques innovadores y proactivos\, como el ultrascreening y las estrategias avanzadas de reducción del riesgo. El ultrascreening utiliza tecnologías de vanguardia\, como las biopsias líquidas y los análisis de sangre para la detección temprana de múltiples tipos de cáncer (MCED)\, para identificar tumores en etapas microscópicas o antes de que presenten síntomas. Combinadas con la evaluación personalizada del riesgo y las intervenciones específicas sobre los hábitos de vida\, estas estrategias buscan detectar el cáncer antes que los métodos tradicionales\, con el objetivo de reducir su incidencia mundial y mejorar la supervivencia de los pacientes. También se analizará el enfoque en poblaciones seleccionadas\, como adultos jóvenes y trabajadores. \nFecha: miércoles 4 de noviembre de 2026\nHorario: 13:30 a 15:30 GMT\nModalidad: online \nOradores\nEduardo Cazap\nSLACOM Founding President; Past-President\, Union for International Cancer Control (UICC). Argentina\nWhy Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem \nCharles Balch\nPresident\, International Society of Oncology Prevention and Treatments (ISOPT); Professor of Surgery\, UT MD Anderson Cancer Center. USA\nInnovative Cancer Prevention Strategies in Young adults and corporate \nJeffrey N. Weitzel\nFounding Director of the Division of Precision Prevention\, The University of Kansas Cancer Center (KUMC). USA\nPersonalized risk assessment (monogenic and polygenic cancer risk assessment) \nSuyapa Bejarano\nDirector\, Scientific Research and Innovation\, Universidad Católica de Honduras (UNICAH). Honduras\nCurrent realities and future Horizons: Cancer Screening Capacity Across Latin America \nJulia Ismael\nUICC Board Member\, Scientific & Technical Director\, Latin American Cancer Institute Network (ILACC). Argentina\nWhy Is Cancer Prevention Falling Short? Bridging the Gap Between Innovation and Population Impact \nMaira Caleffi\nUICC Board Member. Chief of the Breast Cancer Center\, Hospital Moinhos de Vento. Brazil\nCan Patient Advocacy Help Identify High Risk Women and Turn Cancer Prevention Innovation into Equitable Access? \nPrograma\n13:30 to 13:50 GMT | Why Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nEduardo Cazap \n13:50 to 14:10 GMT | Innovative Cancer Prevention Strategies in Young adults and corporate\nCharles Balch \n14:10 to 14:30 GMT | Personalized risk assessment (monogenic and polygenic cancer risk assessment)\nJeffrey N. Weitzel \n14:30 to 14:50 GMT | Current realities and future Horizons: Cancer Screening Capacity Across Latin America\nSuyapa Bejarano \n14:50 to 15:10 GMT | Why Is Cancer Prevention Falling Short? Bridging the Gap Between Innovation and Population Impact\nJulia Ismael \n15:10 to 15:30 GMT | Can Patient Advocacy Help Identify High Risk Women and Turn Cancer Prevention Innovation into Equitable Access?\nMaira Caleffi
URL:https://www.lgcw.org.uk/event/new-and-innovative-strategies-in-global-cancer-prevention-ultrascreening-and-risk-reduction-strategies/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2026/09/Slacom-Logo-20-Years.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T120000
DTEND;TZID=Europe/London:20261104T133000
DTSTAMP:20261030T211828Z
CREATED:20260904T201545Z
LAST-MODIFIED:20261030T211828Z
UID:10000336-1793793600-1793799000@www.lgcw.org.uk
SUMMARY:Why Breast and Cervical Cancer Prevention is Failing—and How to Fix It"
DESCRIPTION:Register \nBreast and cervical cancer are among the most preventable and treatable cancers\, with effective tools available for vaccination\, screening\, early detection\, and treatment. Yet together they cause more than one million deaths every year\, most of them in low- and middle-income countries\, and many of them avoidable. \nThe problem is not a lack of scientific evidence or technology\, but unequal access to the prevention tools already available. Fragmented health systems\, low screening coverage\, loss to follow-up and delayed diagnosis mean that where a woman lives still determines whether she survives. With the WHO Global Strategy for cervical cancer elimination and the Global Breast Cancer Initiative setting clear targets\, the need to close these gaps has never been more urgent. But to achieve real progress\, proven interventions must be combined with innovative strategies adapted to each country and community. \nThis session\, organized by SLACOM and the Center of the Study of State and Society (CEDES)\, will bring together experts from Latin America to discuss why prevention continues to fall short and what it will take to fix it. Speakers will also share experiences and strategies to close equity gaps\, such as mHealth tools that improve screening and follow-up for women with abnormal results\, and discuss their role in accelerating progress toward global cancer control targets. \nDate: Wednesday\, 4th November 2026\nTime: 12:00 p.m. to 1:30 p.m. GMT\nFormat: Online \nSpeakers\n\n\n\nEduardo Cazap\nSLACOM Founding President; Past-President\, Union for International Cancer Control (UICC)\nWhy Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nSilvina Arrossi\nSenior Researcher\, National Scientific and Technical Research Council\, Center for the Study of State and Society (CEDES and CONICET)\nClosing the Gap After HPV Testing: Tita App\, a Digital Tool to Keep Screened Women Connected to Care\nMelisa Paolino\nSenior Scientific Consultant\, Ministry of Health of Argentina / National Cancer Institute; Public Health Researcher\, Center for the Study of State and Society (CEDES and CONICET)\nReaching More Women: Results of the ATICA Trial\, an mHealth Intervention for Breast Cancer Screening\n\n\n\nProgramme\n12:00 to 12:20 GMT | Why Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nEduardo Cazap \n12:20 to 12:40 GMT | Closing the Gap After HPV Testing: Tita App\, a Digital Tool to Keep Screened Women Connected to Care\nSilvina Arrossi \n12:40 to 13:00 GMT | Reaching More Women: Results of the ATICA Trial\, an mHealth Intervention for Breast Cancer Screening\nMelisa Paolino \n\nSESIÓN DE SLACOM Y CEDES · MIÉRCOLES 4 DE NOVIEMBRE DE 2026 \nPor qué está fallando la prevención del cáncer de mama y de cuello uterino\, y cómo solucionarlo\nEl cáncer de mama y el cáncer de cuello uterino se encuentran entre los cánceres más prevenibles y tratables\, y existen herramientas eficaces para la vacunación\, el tamizaje\, la detección temprana y el tratamiento. Sin embargo\, ambos causan en conjunto más de un millón de muertes cada año\, la mayoría en países de ingresos bajos y medios\, muchas de ellas evitables. \nEl problema no es la falta de evidencia científica ni de tecnología\, sino el acceso desigual a las herramientas de prevención disponibles. Los sistemas de salud fragmentados\, la baja cobertura de tamizaje\, la pérdida de seguimiento y los diagnósticos tardíos hacen que el lugar donde vive una mujer siga determinando sus posibilidades de sobrevivir. Con la Estrategia Mundial de la OMS para la eliminación del cáncer de cuello uterino y la Iniciativa Mundial contra el Cáncer de Mama estableciendo objetivos claros\, la necesidad de cerrar estas brechas es urgente. Para lograr avances reales\, las intervenciones probadas deben combinarse con estrategias innovadoras adaptadas a cada país y comunidad. \nEsta sesión\, organizada por SLACOM y el Centro de Estudios de Estado y Sociedad (CEDES)\, reunirá a especialistas de América Latina para analizar por qué la prevención sigue siendo insuficiente y qué se necesita para mejorarla. Los oradores también compartirán experiencias y estrategias para reducir las brechas de equidad\, como herramientas de salud móvil (mHealth) que mejoran el tamizaje y el seguimiento de mujeres con resultados anormales\, y analizarán su papel para acelerar el avance hacia los objetivos mundiales de control del cáncer. \nFecha: miércoles 4 de noviembre de 2026\nHorario: 12:00 a 13:30 GMT\nModalidad: online \nOradores\nEduardo Cazap\nSLACOM Founding President; Past-President\, Union for International Cancer Control (UICC)\nWhy Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem \nSilvina Arrossi\nSenior Researcher\, National Scientific and Technical Research Council\, Center for the Study of State and Society (CEDES and CONICET)\nClosing the Gap After HPV Testing: Tita App\, a Digital Tool to Keep Screened Women Connected to Care \nMelisa Paolino\nSenior Scientific Consultant\, Ministry of Health of Argentina / National Cancer Institute; Public Health Researcher\, Center for the Study of State and Society (CEDES and CONICET)\nReaching More Women: Results of the ATICA Trial\, an mHealth Intervention for Breast Cancer Screening \nPrograma\n12:00 to 12:20 GMT | Why Cancer Prevention is Failing and how to implement innovative strategies to overcome the problem\nEduardo Cazap \n12:20 to 12:40 GMT | Closing the Gap After HPV Testing: Tita App\, a Digital Tool to Keep Screened Women Connected to Care\nSilvina Arrossi \n12:40 to 13:00 GMT | Reaching More Women: Results of the ATICA Trial\, an mHealth Intervention for Breast Cancer Screening\nMelisa Paolino
URL:https://www.lgcw.org.uk/event/why-breast-and-cervical-cancer-prevention-is-failing-and-how-to-fix-it/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2026/09/Slacom-cedes-Logo.png
END:VEVENT
END:VCALENDAR